Autophinib

  • CAT Number: I013218
  • CAS Number: 1644443-47-9
  • Molecular Formula: C₁₄H₁₁ClN₆O₃
  • Molecular Weight: 346.73
  • Purity: ≥95%
Inquiry Now

Autophinib (CAT: I013218) is a small molecule inhibitor that targets the protein kinase VPS34, a key regulator of the autophagy pathway. By inhibiting VPS34, Autophinib can modulate autophagy, a cellular process involved in the degradation and recycling of cellular components. Autophinib has shown potential therapeutic applications in various diseases, including cancer, neurodegenerative disorders, and infectious diseases, where dysregulation of autophagy is implicated. It is currently being studied for its pharmacological activity and therapeutic potential.

Catalog Number I013218
CAS Number 1644443-47-9
Molecular Formula

C₁₄H₁₁ClN₆O₃

Purity 95%
Target Autophagy
Solubility DMSO: ≥ 30 mg/mL
IUPAC Name 6-chloro-N-(5-methyl-1H-pyrazol-3-yl)-2-(4-nitrophenoxy)pyrimidin-4-amine
InChI InChI=1S/C14H11ClN6O3/c1-8-6-13(20-19-8)17-12-7-11(15)16-14(18-12)24-10-4-2-9(3-5-10)21(22)23/h2-7H,1H3,(H2,16,17,18,19,20)
InChIKey CEUMAXLRGBKFQP-UHFFFAOYSA-N
SMILES CC1=CC(=NN1)NC2=CC(=NC(=N2)OC3=CC=C(C=C3)[N+](=O)[O-])Cl
Reference

[1]. Robke L, et al. Phenotypic Identification of a Novel Autophagy Inhibitor Chemotype Targeting Lipid Kinase VPS34. Angew Chem Int Ed Engl. 2017 Jul 3;56(28):8153-8157.

Request a Quote

Contact Us at MuseChem

We are committed to providing you with reliable, cost-effective solutions for your chemical needs, while ensuring your safety and comfort. Our team of experts is always available to answer your questions and help you navigate the complexities of the chemical industry.

Whether you're looking for a specific product or need help with a custom synthesis project, we're here to help you discover a new world of chemical possibilities. Contact us today to learn more about how we can assist you with all of your chemical needs.

Our goal is to make the process of ordering chemicals as seamless and hassle-free as possible. Let us know how we can assist you, and we'll get back to you as soon as possible. We look forward to hearing from you!